Compare California Stem Cell vs Montana Molecular
Customers evaluate the quality of California Stem Cell's products using the following success metrics.
Overview
California Stem Cell is 19 yrs old and is based in United States.
California Stem Cell is focused on the production and supply of clinically relevant human cell populations, and therapeutic application to human disease and injury. CSC has developed methods for scalable production of human motor neurons, neuronal progenitors, cardiac muscle and sino-atrial node cells, at high purity, from hESCs. The company can generate virtually unlimited quantities of differentiated human cells in an FDA-compliant manner that renders these populations clinically relevant. On April 14, 2014, California Stem Cell was acquired by NeoStem. The terms of the transaction were not disclosed.
Montana Molecular is 20 yrs old and is based in United States.
Montana Molecular is a company focused on the development of genetically encoded fluorescent biosensors and probes, operating within the biotechnology and drug discovery sectors. The company's main offerings include fluorescent assays for live cell discovery, which are used to observe and measure cell processes that are crucial in maintaining health and treating diseases. These products and services are primarily targeted towards the drug discovery and research industries. It was founded in 2004 and is based in Bozeman, Montana.
Demo Video
Leadership
Hans S. Keirstead (Chief Executive Officer, President)
Anne Marie Quinn (Chief Executive Officer)
Investors
Caladrius Biosciences and Whiskey Hill Partners
TechRanch
Product
Information not available because California Stem Cell has not claimed their profile.
Work for California Stem Cell? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for California Stem Cell?
Claim your profile now.
Why Montana Molecular beats California Stem Cell
Benefits
- Peer reviewed publications
- Results from pilot projects
- Multimedia protocols
Products
SARS CoV-2 Pseudoviruses
These pseudoviruses are BSL-1 baculoviruses pseudotyped with Spike (S) proteins. This means that biologists and drug discovery teams can work on COVID-19 projects outside of BSL-3 facilities with standard safety procedures.
Customers
Known Partners
Why They Buy